295 related articles for article (PubMed ID: 30574853)
1. Non Nucleoside Reverse Transcriptase Inhibitors, Molecular Docking Studies and Antitubercular Activity of Thiazolidin-4-one Derivatives.
Chitre TS; Patil SM; Sujalegaonkar AG; Asgaonkar KD; Khedkar VM; Garud DR; Jha PC; Gaikwad SY; Kulkarni SS; Choudhari A; Sarkar D
Curr Comput Aided Drug Des; 2019; 15(5):433-444. PubMed ID: 30574853
[TBL] [Abstract][Full Text] [Related]
2. Lead optimization at C-2 and N-3 positions of thiazolidin-4-ones as HIV-1 non-nucleoside reverse transcriptase inhibitors.
Murugesan V; Tiwari VS; Saxena R; Tripathi R; Paranjape R; Kulkarni S; Makwana N; Suryawanshi R; Katti SB
Bioorg Med Chem; 2011 Nov; 19(22):6919-26. PubMed ID: 21982685
[TBL] [Abstract][Full Text] [Related]
3. Targeting HIV-TB coinfection by developing novel piperidin-4-substituted imines: Design, synthesis, in vitro and in silico studies.
Kumar A; Revathi R; Sriram D; Curreli F; Debnath AK; Pai KS; Kini SG
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800358. PubMed ID: 31066103
[TBL] [Abstract][Full Text] [Related]
4. One-Pot Synthesis of Novel Hydrazono-1,3-Thıazolıdın-4-One Derivatives as Anti-HIV and Anti-Tubercular Agents: Synthesıs, Bıologıcal Evaluatıon, Molecular Modelling and Admet Studıes.
Pasha MA; Mondal S; Panigrahi N; Shetye G; Ma R; Franzblau SG; Zheng YT; Murugesan S
Curr HIV Res; 2022; 20(3):255-271. PubMed ID: 35549861
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation and molecular modeling studies of new 2,3-diheteroaryl thiazolidin-4-ones as NNRTIs.
Debnath U; Verma S; Singh P; Rawat K; Gupta SK; Tripathi RK; Siddiqui HH; Katti SB; Prabhakar YS
Chem Biol Drug Des; 2015 Nov; 86(5):1285-91. PubMed ID: 26031778
[TBL] [Abstract][Full Text] [Related]
6. New thiourea and 1,3-thiazolidin-4-one derivatives effective on the HIV-1 virus.
Bielenica A; Sanna G; Madeddu S; Struga M; Jóźwiak M; Kozioł AE; Sawczenko A; Materek IB; Serra A; Giliberti G
Chem Biol Drug Des; 2017 Nov; 90(5):883-891. PubMed ID: 28434186
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, HIV-1 RT inhibitory, antibacterial, antifungal and binding mode studies of some novel N-substituted 5-benzylidine-2,4-thiazolidinediones.
Bahare RS; Ganguly S; Choowongkomon K; Seetaha S
Daru; 2015 Jan; 23(1):6. PubMed ID: 25617150
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of 4-thiazolidinone derivatives as potential reverse transcriptase inhibitors against HIV-1 drug resistant strains.
Suryawanshi R; Jadhav S; Makwana N; Desai D; Chaturbhuj D; Sonawani A; Idicula-Thomas S; Murugesan V; Katti SB; Tripathy S; Paranjape R; Kulkarni S
Bioorg Chem; 2017 Apr; 71():211-218. PubMed ID: 28236450
[TBL] [Abstract][Full Text] [Related]
9. Rational design and synthesis of novel thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Murugesan V; Makwana N; Suryawanshi R; Saxena R; Tripathi R; Paranjape R; Kulkarni S; Katti SB
Bioorg Med Chem; 2014 Jun; 22(12):3159-70. PubMed ID: 24794742
[TBL] [Abstract][Full Text] [Related]
10. Molecular modeling, synthesis and biological evaluation of N-heteroaryl compounds as reverse transcriptase inhibitors against HIV-1.
Singh A; Yadav D; Yadav M; Dhamanage A; Kulkarni S; Singh RK
Chem Biol Drug Des; 2015 Mar; 85(3):336-47. PubMed ID: 25055732
[TBL] [Abstract][Full Text] [Related]
11. Novel Thiazolidin-4-ones as Potential Non-nucleoside Inhibitors of HIV-1 Reverse Transcriptase.
Petrou A; Eleftheriou P; Geronikaki A; Akrivou MG; Vizirianakis I
Molecules; 2019 Oct; 24(21):. PubMed ID: 31652782
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in-vitro anti-HIV-1 evaluation of novel pyrazolo[4,3-c]pyridin-4-one derivatives.
Kumar S; Gupta S; Abadi LF; Gaikwad S; Desai D; Bhutani KK; Kulkarni S; Singh IP
Eur J Med Chem; 2019 Dec; 183():111714. PubMed ID: 31557609
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of novel 5-Alkyl-6-Adamantylmethylpyrimidin-4(3H)-ones as HIV-1 non-nucleoside reverse-transcriptase inhibitors.
Li W; Huang B; Kang D; De Clercq E; Daelemans D; Pannecouque C; Zhan P; Liu X
Chem Biol Drug Des; 2016 Sep; 88(3):380-5. PubMed ID: 27062197
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and anti-HIV-1 activity of 1-aromatic methyl-substituted 3-(3,5-dimethylbenzyl)uracil and N-3,5-dimethylbenzyl-substituted urea derivatives.
Sakakibara N; Baba M; Okamoto M; Toyama M; Demizu Y; Misawa T; Kurihara M; Irie K; Kato Y; Maruyama T
Antivir Chem Chemother; 2015 Feb; 24(1):3-18. PubMed ID: 26149262
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
Lokesh BVS; Prasad YR; Shaik AB
Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HIV-1 RT activity by a new series of 3-(1,3,4-thiadiazol-2-yl)thiazolidin-4-one derivatives.
Buemi MR; Gitto R; Ielo L; Pannecouque C; De Luca L
Bioorg Med Chem; 2020 Apr; 28(8):115431. PubMed ID: 32197813
[TBL] [Abstract][Full Text] [Related]
17. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives targeting the entrance channel of NNRTI binding pocket.
Yang J; Chen W; Kang D; Lu X; Li X; Liu Z; Huang B; Daelemans D; Pannecouque C; De Clercq E; Zhan P; Liu X
Eur J Med Chem; 2016 Feb; 109():294-304. PubMed ID: 26802545
[TBL] [Abstract][Full Text] [Related]
19. Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1.
Jin K; Yin H; De Clercq E; Pannecouque C; Meng G; Chen F
Eur J Med Chem; 2018 Feb; 145():726-734. PubMed ID: 29353724
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of 3-benzyloxy-linked pyrimidinylphenylamine derivatives as potent HIV-1 NNRTIs.
Rai D; Chen W; Tian Y; Chen X; Zhan P; De Clercq E; Pannecouque C; Balzarini J; Liu X
Bioorg Med Chem; 2013 Dec; 21(23):7398-405. PubMed ID: 24134904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
